Search Orphan Drug Designations and Approvals
-
Generic Name: | N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl-phenyl]-acetamide |
---|---|
Date Designated: | 04/08/2021 |
Orphan Designation: | Treatment of epileptic encephalopathy with continuous spike-wave discharges during sleep (EECSWS) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Neurocrine Biosciences Inc. 12780 El Camino Real San Diego, California 92130 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-